logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
PrescriberPoint
HIPPA Logo
HIPPA COMPLIANT
HIPPA Logo
Soc 2 Type II
PrescriberPoint
HIPPA Logo
HIPPA COMPLIANT
HIPPA Logo
Soc 2 Type II
For ProvidersRequest DemoJoin Research Panel
Prescribing toolsPrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyPartnershipsAboutCareersContact Us
Get the latest insights in your inbox
  • Terms and Conditions
  • Privacy Policy
  • © 2026 PrescriberPoint. All Rights Reserved.

    • Rising Pharmaceuticals, Inc. drugs

    FiltersReset Filters
    7 results

    • fluocinolone acetonide

      (Fluocinolone Acetonide)
      Rising Pharmaceuticals, Inc.
      Usage: Fluocinolone acetonide topical oil, 0.01% is indicated for the treatment of scalp psoriasis in adult patients.

    • glipizide

      (Glipizide)
      Rising Pharmaceuticals, Inc.
      Usage: Glipizide extended-release tablets are indicated for the management of type 2 diabetes mellitus. However, they are not recommended for treating type 1 diabetes or diabetic ketoacidosis.

    • lactulose solution

      (Lactulose Solution USP, 10 g/15 mL)
      Rising Pharmaceuticals, Inc.
      Usage: Lactulose is indicated for the prevention and treatment of portal-systemic encephalopathy, including hepatic pre-coma and coma. It effectively reduces blood ammonia levels, improves mental state, and enhances EEG patterns, with a positive clinical response in about 75% of patients, often increasing protein tolerance.

    • levocarnitine

      (Levocarnitine)
      Rising Pharmaceuticals, Inc.
      Usage: Levocarnitine Oral Solution is indicated for treating primary systemic carnitine deficiency and secondary carnitine deficiency due to inborn metabolic errors, presenting with symptoms such as Reye-like encephalopathy, hypoketotic hypoglycemia, and cardiomyopathy. Treatment should be complemented with supportive care as needed.

    • midodrine hydrochloride

      (Midodrine Hydrochloride)
      Rising Pharmaceuticals, Inc.
      Usage: Midodrine hydrochloride tablets are indicated for treating symptomatic orthostatic hypotension in patients whose lives are significantly impaired despite standard care. Its use is based on effects on standing blood pressure, though clinical benefits have yet to be established. Continued use requires significant symptomatic improvement.

    • ofloxacin

      (Ofloxacin)
      Rising Pharmaceuticals, Inc.
      Usage: Ofloxacin otic solution 0.3% is indicated for treating Otitis Externa in patients 6 months and older and Chronic Suppurative Otitis Media in those 12 years and older. It is also used for Acute Otitis Media in pediatric patients 1 year and older with tympanostomy tubes, targeting specific bacteria.

    • pyridostigmine bromide

      (Pyridostigmine Bromide)
      Rising Pharmaceuticals, Inc.